Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (247)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
116
1.930
 Why?
Thyroidectomy
13
2019
61
1.780
 Why?
Parathyroidectomy
8
2018
46
1.260
 Why?
Thyroid Diseases
6
2019
27
1.210
 Why?
Parathyroid Neoplasms
5
2015
27
1.060
 Why?
Thyroid Gland
7
2017
78
1.010
 Why?
Parathyroid Hormone
8
2019
151
0.930
 Why?
Adenoma
4
2017
113
0.930
 Why?
Vitamin D Deficiency
5
2019
46
0.920
 Why?
Vitamin D
4
2015
90
0.790
 Why?
Fluorodeoxyglucose F18
6
2013
188
0.720
 Why?
Positron-Emission Tomography
7
2013
303
0.700
 Why?
Radiopharmaceuticals
7
2015
205
0.690
 Why?
Carcinoma, Papillary
4
2017
51
0.690
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.670
 Why?
Hyperparathyroidism, Primary
4
2018
35
0.640
 Why?
Hyperparathyroidism
2
2015
31
0.580
 Why?
Iodine Radioisotopes
3
2015
34
0.550
 Why?
Megestrol Acetate
2
2007
17
0.510
 Why?
Parathyroid Diseases
2
2016
5
0.510
 Why?
Bone Density Conservation Agents
2
2007
75
0.500
 Why?
Nursing Homes
2
2007
112
0.500
 Why?
Incidental Findings
3
2013
43
0.470
 Why?
Proton Pump Inhibitors
1
2015
86
0.460
 Why?
Diphosphonates
1
2015
92
0.450
 Why?
Academic Medical Centers
2
2012
150
0.440
 Why?
Thyroglobulin
2
2013
7
0.440
 Why?
Parathyroid Glands
5
2018
20
0.420
 Why?
Carcinoma, Medullary
2
2010
12
0.420
 Why?
Aged
19
2017
10181
0.410
 Why?
Middle Aged
25
2017
13081
0.410
 Why?
Hypothyroidism
2
2011
57
0.380
 Why?
Male
31
2019
26816
0.370
 Why?
Retrospective Studies
14
2019
6661
0.360
 Why?
Calcitonin
2
2010
30
0.360
 Why?
Postoperative Complications
5
2018
1080
0.360
 Why?
Carcinoma
2
2012
137
0.340
 Why?
Humans
44
2019
52513
0.330
 Why?
Algorithms
1
2013
667
0.320
 Why?
Thyroid Nodule
3
2017
31
0.320
 Why?
Female
29
2019
28219
0.300
 Why?
Weight Loss
2
2009
250
0.300
 Why?
Appetite Stimulants
1
2007
5
0.270
 Why?
Cachexia
1
2007
28
0.270
 Why?
Aged, 80 and over
9
2017
3414
0.270
 Why?
Teriparatide
1
2007
10
0.260
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.250
 Why?
Calcium
3
2018
374
0.250
 Why?
Hypocalcemia
2
2016
13
0.240
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.240
 Why?
Hormones
1
2005
59
0.240
 Why?
Phenylurea Compounds
2
2015
18
0.240
 Why?
Osteoporosis
1
2007
162
0.240
 Why?
Quinolines
2
2015
44
0.230
 Why?
Transcriptional Activation
1
2005
128
0.230
 Why?
Pituitary Gland
1
2005
89
0.230
 Why?
Receptors, Estrogen
1
2005
132
0.230
 Why?
Interleukin-6
1
2005
277
0.220
 Why?
NF-kappa B
1
2005
329
0.210
 Why?
Biopsy, Fine-Needle
5
2011
104
0.210
 Why?
Protein Kinase Inhibitors
2
2015
228
0.200
 Why?
Illinois
2
2013
11
0.200
 Why?
Treatment Outcome
8
2015
5480
0.190
 Why?
Adult
13
2017
14148
0.180
 Why?
Gene Expression Regulation
1
2005
1004
0.170
 Why?
Aging
1
2005
706
0.170
 Why?
Young Adult
7
2015
4326
0.160
 Why?
Follow-Up Studies
3
2013
2290
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.150
 Why?
Postoperative Period
3
2015
171
0.150
 Why?
Preoperative Care
2
2018
174
0.140
 Why?
Vitamins
2
2018
64
0.140
 Why?
Patient Discharge
3
2016
326
0.140
 Why?
Intraoperative Complications
1
2019
113
0.140
 Why?
Insulin Resistance
2
2009
278
0.130
 Why?
Prospective Studies
2
2013
2451
0.130
 Why?
United States
5
2015
5225
0.130
 Why?
Antineoplastic Agents
2
2015
1219
0.130
 Why?
Predictive Value of Tests
3
2015
949
0.130
 Why?
Reoperation
1
2018
465
0.120
 Why?
Incidence
2
2011
1076
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Adolescent
5
2015
6725
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
25
0.120
 Why?
Creatinine
1
2015
159
0.120
 Why?
Lymph Nodes
1
2017
252
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
50
0.120
 Why?
Costs and Cost Analysis
2
2014
96
0.120
 Why?
Disease Progression
3
2015
872
0.120
 Why?
Molecular Targeted Therapy
1
2015
133
0.110
 Why?
Diagnosis, Differential
6
2018
1045
0.110
 Why?
Ambulatory Care
1
2016
239
0.110
 Why?
Neoplasm Metastasis
2
2015
238
0.110
 Why?
Hospitals, University
1
2014
75
0.110
 Why?
Child, Preschool
2
2013
4056
0.110
 Why?
Sensitivity and Specificity
2
2013
882
0.100
 Why?
Liver
2
2009
1156
0.100
 Why?
Exercise
2
2009
548
0.100
 Why?
Drug Administration Schedule
1
2013
375
0.100
 Why?
Hospitals, Teaching
1
2013
53
0.100
 Why?
Technetium
1
2012
8
0.100
 Why?
Preoperative Period
1
2012
47
0.100
 Why?
Administration, Oral
1
2013
455
0.100
 Why?
Clinical Competence
2
2018
400
0.100
 Why?
Patient Compliance
1
2013
230
0.100
 Why?
Radionuclide Imaging
1
2012
107
0.100
 Why?
Outpatients
1
2013
126
0.100
 Why?
Hospital Charges
1
2012
47
0.100
 Why?
Tumor Burden
1
2012
136
0.090
 Why?
Struma Ovarii
1
2012
5
0.090
 Why?
Cost Savings
1
2012
58
0.090
 Why?
Prognosis
3
2015
2115
0.090
 Why?
Ovariectomy
1
2012
113
0.090
 Why?
Child
3
2013
7218
0.090
 Why?
Immunohistochemistry
2
2012
981
0.090
 Why?
Obesity
2
2009
1164
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1372
0.080
 Why?
Radiation Monitoring
1
2010
7
0.080
 Why?
Inpatients
1
2011
209
0.080
 Why?
Radiosurgery
1
2011
129
0.080
 Why?
Checklist
1
2010
40
0.080
 Why?
Fatal Outcome
1
2010
195
0.080
 Why?
Databases, Factual
1
2013
715
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
38
0.080
 Why?
Ultrasonography
4
2015
424
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
General Surgery
1
2010
105
0.070
 Why?
Occupational Exposure
1
2010
110
0.070
 Why?
Blastomycosis
1
2008
30
0.070
 Why?
Receptors, Thyrotropin
1
2007
6
0.070
 Why?
Symporters
1
2007
15
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Time Factors
3
2015
2997
0.070
 Why?
Ovarian Neoplasms
1
2012
460
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Whole Body Imaging
1
2007
26
0.070
 Why?
Severity of Illness Index
1
2011
1035
0.070
 Why?
Adiposity
1
2009
143
0.070
 Why?
DNA, Neoplasm
1
2007
146
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Promoter Regions, Genetic
2
2007
474
0.070
 Why?
Drug Utilization Review
1
2006
22
0.070
 Why?
Drug Monitoring
1
2006
82
0.060
 Why?
Head
1
2006
70
0.060
 Why?
Cross-Sectional Studies
2
2014
1682
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
856
0.060
 Why?
Geriatrics
1
2006
47
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Body Mass Index
2
2009
691
0.060
 Why?
Neck
1
2006
97
0.060
 Why?
Proportional Hazards Models
1
2007
444
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
10
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Faculty, Medical
1
2006
91
0.060
 Why?
Arkansas
2
2014
2029
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Fractures, Bone
1
2006
107
0.060
 Why?
Survival Analysis
1
2007
673
0.060
 Why?
DNA Primers
1
2005
206
0.060
 Why?
Reproducibility of Results
3
2017
1216
0.060
 Why?
Internship and Residency
1
2010
441
0.060
 Why?
HeLa Cells
1
2005
261
0.060
 Why?
Base Sequence
1
2005
634
0.060
 Why?
Nuclear Proteins
1
2005
246
0.050
 Why?
Protein Binding
1
2005
671
0.050
 Why?
Infant
1
2012
3713
0.050
 Why?
ROC Curve
2
2015
254
0.050
 Why?
Patient Selection
2
2018
266
0.050
 Why?
Intraoperative Period
2
2015
46
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
600
0.050
 Why?
Tomography, X-Ray Computed
3
2012
1161
0.040
 Why?
Thalidomide
1
2002
378
0.040
 Why?
Glucagon
2
2009
24
0.040
 Why?
Cohort Studies
2
2015
1551
0.040
 Why?
Monitoring, Intraoperative
1
2019
52
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
47
0.040
 Why?
Risk Factors
1
2006
3951
0.040
 Why?
Pilot Projects
2
2010
719
0.030
 Why?
Methylene Blue
1
2017
7
0.030
 Why?
Lymphatic System
1
2017
12
0.030
 Why?
Animals, Genetically Modified
1
2017
52
0.030
 Why?
Societies, Medical
1
2018
202
0.030
 Why?
Coloring Agents
1
2017
68
0.030
 Why?
Mice, Inbred Strains
1
2017
164
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
80
0.030
 Why?
Insulin
2
2009
484
0.030
 Why?
Recurrence
1
2018
681
0.030
 Why?
Lymphatic Metastasis
1
2017
211
0.030
 Why?
Bone Density
1
2018
399
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
58
0.030
 Why?
Brachial Plexus
1
2015
12
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
92
0.030
 Why?
Hematoma
1
2015
68
0.030
 Why?
Transplantation, Autologous
1
2015
488
0.030
 Why?
Neoplasm Staging
1
2015
767
0.020
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
30
0.020
 Why?
Mutation
1
2017
1342
0.020
 Why?
Ribs
1
2010
16
0.020
 Why?
Thoracotomy
1
2010
33
0.020
 Why?
Neck Dissection
1
2010
29
0.020
 Why?
Mediastinal Neoplasms
1
2010
18
0.020
 Why?
Hypercalcemia
1
2010
34
0.020
 Why?
Feasibility Studies
1
2011
403
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
70
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Hospitalization
1
2014
749
0.020
 Why?
Prevalence
1
2012
1017
0.020
 Why?
Glucose Tolerance Test
1
2009
61
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Postmenopause
1
2009
81
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
237
0.020
 Why?
Absorptiometry, Photon
1
2009
162
0.020
 Why?
Eye
1
2008
25
0.020
 Why?
Bone Neoplasms
1
2010
184
0.020
 Why?
Iodine
1
2007
12
0.020
 Why?
Methylation
1
2007
126
0.020
 Why?
Body Weight
1
2009
523
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
642
0.020
 Why?
Multiple Myeloma
1
2002
3050
0.020
 Why?
Overweight
1
2009
224
0.020
 Why?
Current Procedural Terminology
1
2006
11
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Mice
1
2017
5943
0.020
 Why?
Office Visits
1
2006
45
0.020
 Why?
Polymerase Chain Reaction
1
2007
460
0.020
 Why?
Genetic Predisposition to Disease
1
2009
527
0.020
 Why?
Blood Glucose
1
2009
473
0.020
 Why?
Risk Assessment
1
2010
1348
0.010
 Why?
Lung
1
2008
500
0.010
 Why?
Muscle, Skeletal
1
2009
809
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Animals
1
2017
13464
0.010
 Why?
Clinical Trials as Topic
1
2002
472
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (247) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department